SEC Form 4 research
| Issuer | NRX Pharmaceuticals, Inc. |
|---|---|
| Tickers | NRXP, BRPAU, BRPA |
| Reporting owners | 33 |
| Officers and directors | 9 |
| Last public filing | 2026-11-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-07-28 | ABRAMS MICHAEL S | A | 75,000 | $0 | Not reported |
| 2026-11-04 | 2026-07-28 | Javitt Jonathan C | A | 150,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.